VAC14-AS1

 

Full name: VAC14 antisense RNA 1 Alias Symbol: 
Type: non-coding RNA Cytoband: 16q22.1
Entrez ID: 100130894 HGNC ID: HGNC:48605 Ensembl Gene: ENSG00000214353 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of VAC14-AS1:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 VAC14-AS1 100130894 1564158_a_at -0.1389 0.5667
GSE26886 VAC14-AS1 100130894 1564158_a_at -0.1457 0.1358
GSE45670 VAC14-AS1 100130894 1564158_a_at -0.0400 0.7370
GSE53622 VAC14-AS1 100130894 8043 0.8182 0.0000
GSE53624 VAC14-AS1 100130894 8043 0.9199 0.0000
GSE63941 VAC14-AS1 100130894 1564158_a_at -0.0627 0.6562
GSE77861 VAC14-AS1 100130894 1564158_a_at -0.0615 0.4754
SRP133303 VAC14-AS1 100130894 RNAseq 0.3251 0.0316
SRP159526 VAC14-AS1 100130894 RNAseq -0.3561 0.4888
SRP193095 VAC14-AS1 100130894 RNAseq 0.2287 0.1403
SRP219564 VAC14-AS1 100130894 RNAseq 0.0457 0.9496

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by VAC14-AS1 expression:

 

GSE53622GSE53624

 

Note: Click image to view full size file.  


Copy number change of VAC14-AS1:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 VAC14-AS1 100130894 5 1 24
GSE20123 VAC14-AS1 100130894 6 1 23
GSE43470 VAC14-AS1 100130894 2 8 33
GSE46452 VAC14-AS1 100130894 38 1 20
GSE47630 VAC14-AS1 100130894 11 8 21
GSE54993 VAC14-AS1 100130894 2 4 64
GSE54994 VAC14-AS1 100130894 8 10 35
GSE60625 VAC14-AS1 100130894 4 0 7
GSE74703 VAC14-AS1 100130894 2 5 29
GSE74704 VAC14-AS1 100130894 3 0 17

Total number of gains: 81; Total number of losses: 38; Total Number of normals: 273.  


 

Somatic mutations of VAC14-AS1:

 

Generating mutation plots.

 

Highly correlated genes for VAC14-AS1:

 

Showing all 9 correlated genes with mean PCC>0.5.

Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
VAC14-AS1NSMF0.600338303
VAC14-AS1SRRM40.560393303
VAC14-AS1LINC013510.559434303
VAC14-AS1PLOD20.557656303
VAC14-AS1MMP140.521586303
VAC14-AS1KCNS20.519344503
VAC14-AS1APCS0.51781303
VAC14-AS1SLC24A20.511581403
VAC14-AS1DLX20.510716403

For details and further investigation, click here